Abstract:Both sterol carrier protein-2/sterol carrier protein-x (SCP-2/SCP-x) and liver fatty acid binding protein (L-FABP) have been proposed to function in hepatobiliary bile acid metabolism/accumulation. To begin to address this issue, the impact of ablating L-FABP (LKO) or SCP-2/SCP-x (DKO) individually or both together (TKO) was examined in female mice. Biliary bile acid levels were decreased in LKO, DKO, and TKO mice; however, hepatic bile acid concentration was decreased in LKO mice only. In contrast, biliary ph… Show more
“…Both Fabp1 [60,63,65] and Scp2/Scpx [72,112,114,121] gene products bind, enhance uptake, facilitate metabolism, and function in removal of cholesterol from the liver into bile. Therefore, the impact of sex and TKO on the hepatic accumulation of cholesterol was determined in HFD fed mice.…”
Section: Resultsmentioning
confidence: 99%
“…FABP1 facilitates cytosolic transport of cholesterol to the plasma membrane for secretion of cholesterol as lipoprotein [2,89], to the endoplasmic reticulum for esterification by ACAT2 [49], or to bile canaliculi for biliary cholesterol excretion [36,63,121]. Similarly, SCP2 also facilitates cholesterol transfer from the plasma membrane to the endoplasmic reticulum [29,102] for esterification by ACAT2 [34,86], to mitochondria and peroxisomes for oxidation to steroids [13,14] or bile acids [30,54,81], and to bile canaliculi for biliary excretion [36,54,121].…”
Section: Resultsmentioning
confidence: 99%
“…Genomic studies suggest that a very prevalent SNP in human FABP1 resulting in a T94A amino acid substitution is highly associated with NAFLD [77,96]. FABP1 is the single most prevalent liver cytosolic protein that binds, transports, and targets bound lipidic ligands such as long chain fatty acids and their CoA thioesters [46,74], endocannabinoids [45], bile acids [63], cholesterol [65], and lipidic xenobiotics [47,73,77] to intracellular organelles for storage, oxidation, receptor regulation, or gene regulation. FABP1 is upregulated in human NAFLD and in NAFLD animal models [10,17,38,124].…”
Although singly ablating Fabp1 or Scp2/Scpx genes may exacerbate the impact of high fat diet (HFD) on whole body phenotype and non-alcoholic fatty liver disease (NAFLD), concomitant upregulation of the non-ablated gene, preference for ad libitum fed HFD, and sex differences complicate interpretation. Therefore, these issues were addressed in male and female mice ablated in both genes (Fabp1/Scp2/Scpx null or TKO) and pair-fed HFD. Wild-type (WT) males gained more body weight as fat tissue mass (FTM) and exhibited higher hepatic lipid accumulation than WT females. The greater hepatic lipid accumulation in WT males was associated with higher hepatic expression of enzymes in glyceride synthesis, higher hepatic bile acids, and upregulation of transporters involved in hepatic reuptake of serum bile acids. While TKO had little effect on whole body phenotype and hepatic bile acid accumulation in either sex, TKO increased hepatic accumulation of lipids in both, specifically phospholipid and cholesteryl esters in males and females and free cholesterol in females. TKO-induced increases in glycerides were attributed not only to complete loss of FABP1, SCP2 and SCPx, but also in part to sex-dependent upregulation of hepatic lipogenic enzymes. These data with WT and TKO mice pair-fed HFD indicate that: i) Sex significantly impacted the ability of HFD to increase body weight, induce hepatic lipid accumulation and increase hepatic bile acids; and ii) TKO exacerbated the HFD ability to induce hepatic lipid accumulation, regardless of sex, but did not significantly alter whole body phenotype in either sex.
“…Both Fabp1 [60,63,65] and Scp2/Scpx [72,112,114,121] gene products bind, enhance uptake, facilitate metabolism, and function in removal of cholesterol from the liver into bile. Therefore, the impact of sex and TKO on the hepatic accumulation of cholesterol was determined in HFD fed mice.…”
Section: Resultsmentioning
confidence: 99%
“…FABP1 facilitates cytosolic transport of cholesterol to the plasma membrane for secretion of cholesterol as lipoprotein [2,89], to the endoplasmic reticulum for esterification by ACAT2 [49], or to bile canaliculi for biliary cholesterol excretion [36,63,121]. Similarly, SCP2 also facilitates cholesterol transfer from the plasma membrane to the endoplasmic reticulum [29,102] for esterification by ACAT2 [34,86], to mitochondria and peroxisomes for oxidation to steroids [13,14] or bile acids [30,54,81], and to bile canaliculi for biliary excretion [36,54,121].…”
Section: Resultsmentioning
confidence: 99%
“…Genomic studies suggest that a very prevalent SNP in human FABP1 resulting in a T94A amino acid substitution is highly associated with NAFLD [77,96]. FABP1 is the single most prevalent liver cytosolic protein that binds, transports, and targets bound lipidic ligands such as long chain fatty acids and their CoA thioesters [46,74], endocannabinoids [45], bile acids [63], cholesterol [65], and lipidic xenobiotics [47,73,77] to intracellular organelles for storage, oxidation, receptor regulation, or gene regulation. FABP1 is upregulated in human NAFLD and in NAFLD animal models [10,17,38,124].…”
Although singly ablating Fabp1 or Scp2/Scpx genes may exacerbate the impact of high fat diet (HFD) on whole body phenotype and non-alcoholic fatty liver disease (NAFLD), concomitant upregulation of the non-ablated gene, preference for ad libitum fed HFD, and sex differences complicate interpretation. Therefore, these issues were addressed in male and female mice ablated in both genes (Fabp1/Scp2/Scpx null or TKO) and pair-fed HFD. Wild-type (WT) males gained more body weight as fat tissue mass (FTM) and exhibited higher hepatic lipid accumulation than WT females. The greater hepatic lipid accumulation in WT males was associated with higher hepatic expression of enzymes in glyceride synthesis, higher hepatic bile acids, and upregulation of transporters involved in hepatic reuptake of serum bile acids. While TKO had little effect on whole body phenotype and hepatic bile acid accumulation in either sex, TKO increased hepatic accumulation of lipids in both, specifically phospholipid and cholesteryl esters in males and females and free cholesterol in females. TKO-induced increases in glycerides were attributed not only to complete loss of FABP1, SCP2 and SCPx, but also in part to sex-dependent upregulation of hepatic lipogenic enzymes. These data with WT and TKO mice pair-fed HFD indicate that: i) Sex significantly impacted the ability of HFD to increase body weight, induce hepatic lipid accumulation and increase hepatic bile acids; and ii) TKO exacerbated the HFD ability to induce hepatic lipid accumulation, regardless of sex, but did not significantly alter whole body phenotype in either sex.
“…FABP1 impacts hepatic lipid accumulation not only by decreasing hepatic LCFA β-oxidation (see above), but also in part by its ability to influence biliary secretion of HDL-derived cholesterol and alter bile acid profile (34, 84, 85). FABP1 gene ablation decreases hepatic uptake and biliary secretion of high density lipoprotein (HDL)-derived NBD-cholesterol (34).…”
Section: Fabp1’s Role In Hepatic Lipid Accumulationmentioning
The first discovered member of the mammalian FABP family, liver fatty acid binding protein (FABP1, L-FABP), occurs at high cytosolic concentration in liver, intestine and in the case of humans also in kidney. While the rat FABP1 is well studied, the extent these findings translate to human FABP1 is not clear—especially in view of recent studies showing that endocannabinoids and cannabinoids represent novel rat FABP1 ligands and FABP1 gene ablation impacts the hepatic endocannabinoid system, known to be involved in non-alcoholic fatty liver (NAFLD) development. Although not detectable in brain, FABP1 ablation nevertheless also impacts brain endocannabinoids. Despite overall tertiary structure similarity, human FABP1 differs significantly from rat FABP1 in secondary structure, much larger ligand binding cavity, and affinities/specificities for some ligands. Moreover, while both mouse and human FABP1 mediate ligand induction of peroxisome proliferator activated receptor-α, (PPARα), they differ markedly in pattern of genes induced. This is critically important because a highly prevalent human SNP (26–38% minor allele frequency and 8.3±1.9% homozygous) results in a FABP1 T94A substitution that further accentuates these species differences. The human FABP1 T94A variant is associated with altered body mass index (BMI), clinical dyslipidemias (elevated plasma triglycerides and LDL cholesterol), atherothrombotic cerebral infarction, and non-alcoholic fatty liver disease (NAFLD). Resolving human FABP1 and the T94A variant’s impact on the endocannabinoid and cannabinoid system is an exciting challenge due to the importance of this system on hepatic lipid accumulation as well as behavior, pain, inflammation, and satiety.
“…L-FABP has high affinity for branched-chain lipids such as phytol-derived phytanic and pristanic acids [19,20], cholesterol [21], bile acids [22,23], and lipidic xenobiotics [24-26,26-31]. In vitro studies with cultured cells show that L-FABP enhances the uptake and peroxisomal oxidation of branched-chain fatty acids [7,9,10].…”
In vitro studies suggest that liver fatty acid binding protein (L-FABP) and sterol carrier protein-2/sterol carrier protein-x (SCP2/SCPx) gene products facilitate uptake and metabolism and detoxification of dietary-derived phytol in mammals. However, concomitant upregulation of L-FABP in SCP2/SCPx null mice complicates interpretation of their physiological phenotype. Therefore, the impact of ablating both the L-FABP gene and SCP2/SCPx gene (L-FABP/SCP2/SCPx null or TKO) was examined in phytol-fed female wild-type (WT) and TKO mice. TKO increased hepatic total lipid accumulation, primarily phospholipid, by mechanisms involving increased hepatic levels of proteins in the phospholipid synthetic pathway. Concomitantly, TKO reduced expression of proteins in targeting fatty acids towards the triacylglycerol synthetic pathway. Increased hepatic lipid accumulation was not associated with any concomitant upregulation of membrane fatty acid transport/translocase proteins involved in fatty acid uptake (FATP2, FATP4, FATP5 or GOT) or cytosolic proteins involved in fatty acid intracellular targeting (ACBP). In addition, TKO exacerbated dietary phytol-induced whole body weight loss, especially lean tissue mass. Since individually ablating SCPx or SCP2/SCPx elicited concomitant upregulation of L-FABP, these findings with TKO mice help to resolve the contributions of SCP2/SCPx gene ablation on dietary phytol-induced whole body and hepatic lipid phenotype independent of concomitant upregulation of L-FABP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.